Pär Stattin

发表

How to model temporal changes in comorbidity for cancer patients using prospective cohort data

David Robinson, Lars Lindhagen, Mieke Van Hemelrijck, 2015, BMC Medical Informatics and Decision Making.

How to measure temporal changes in care pathways for chronic diseases using health care registry data

Lars Lindhagen, Pär Stattin, Hans Garmo, 2019, BMC Medical Informatics and Decision Making.

Constrained randomization and multivariate effect projections improve information extraction and biomarker pattern discovery in metabolomics studies involving dependent samples

Pär Stattin, Henrik Antti, Pernilla Wikström, 2015, Metabolomics.

Nordic biological specimen banks as basis for studies of cancer causes and control – more than 2 million sample donors, 25 million person years and 100 000 prospective cancers

Pär Stattin, Vilmundur Gudnason, Joakim Dillner, 2007, Acta oncologica.

Identification of a new prostate cancer susceptibility locus on chromosome 8q24

Peter Kraft, Pär Stattin, Nilanjan Chatterjee, 2009, Nature Genetics.

Cumulative association of five genetic variants with prostate cancer.

Pär Stattin, Fredrik Wiklund, Jianfeng Xu, 2008, The New England journal of medicine.

A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor.

Gerhard Dürnberger, Pär Stattin, Christoph Bock, 2017, Nature chemical biology.

Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults

Anders Engeland, Håkan Jonsson, Pär Stattin, 2012, International journal of cancer.

Association of a germ-line copy number variation at 2p24.3 and risk for aggressive prostate cancer.

Pär Stattin, Fredrik Wiklund, Jianfeng Xu, 2009, Cancer research.

Accuracy of prostate biopsies for predicting Gleason score in radical prostatectomy specimens: nationwide trends 2000–2012

Pär Stattin, David Robinson, Brett Delahunt, 2017, BJU international.

Both high and low levels of blood vitamin D are associated with a higher prostate cancer risk: A longitudinal, nested case‐control study in the Nordic countries

Pär Stattin, Joakim Dillner, Timo Hakulinen, 2004, International journal of cancer.

Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.

Pär Stattin, David Robinson, Lars Egevad, 2016, European urology.

Blood Biomarker Levels to Aid Discovery of Cancer-Related Single-Nucleotide Polymorphisms: Kallikreins and Prostate Cancer

Andrew J. Vickers, Pär Stattin, Fredrik Wiklund, 2010, Cancer Prevention Research.

Mortality in older men with low-risk prostate cancer and high comorbidity.

Pär Stattin, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Transforming growth factor β1 is associated with angiogenesis, metastasis, and poor clinical outcome in prostate cancer

Pär Stattin, Pernilla Wikström, P. Stattin, 1998, The Prostate.

Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy.

Pär Stattin, Hans Garmo, Stefan Carlsson, 2014, The Journal of urology.

Correspondence re: B-L. Adam et al., Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. Cancer Res., 62: 3609-3614, 2002.

Pär Stattin, P. Stattin, M. Hakama, 2003, Cancer research.

Pooled cohort study on height and risk of cancer and cancer death

Anders Engeland, Håkan Jonsson, Pär Stattin, 2013, Cancer Causes & Control.

Low endoglin vascular density and Ki67 index in Gleason score 6 tumours may identify prostate cancer patients suitable for surveillance

Pär Stattin, Andreas Josefsson, Lars Egevad, 2012, Scandinavian journal of urology and nephrology.

Absolute and relative risk of cardiovascular disease in men with prostate cancer: results from the Population-Based PCBaSe Sweden.

Mats Lambe, Pär Stattin, Hans Garmo, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol

Pär Stattin, Henrik Antti, Thomas Moritz, 2010, PloS one.

The National Prostate Cancer Register of Sweden

Pär Stattin, David Robinson, P. Stattin, 2017, Tijdschrift voor Urologie.

Prostate specific antigen for early detection of prostate cancer: longitudinal study

Pär Stattin, Mattias Johansson, Göran Hallmans, 2009, BMJ : British Medical Journal.

Outcomes in Localized Prostate Cancer: National Prostate Cancer Register of Sweden Follow-up Study

Pär Stattin, Erik Holmberg, L. Holmberg, 2010, Journal of the National Cancer Institute.

H6D polymorphism in macrophage-inhibitory cytokine-1 gene associated with prostate cancer.

Pär Stattin, Fredrik Wiklund, Jianfeng Xu, 2004, Journal of the National Cancer Institute.

Genetic Variants in the LEPR, CRY1, RNASEL, IL4, and ARVCF Genes Are Prognostic Markers of Prostate Cancer-Specific Mortality

Pär Stattin, Elaine A. Ostrander, Fredrik Wiklund, 2011, Cancer Epidemiology, Biomarkers & Prevention.

The Proteome of Primary Prostate Cancer.

Pär Stattin, Jürgen Cox, Matthias Mann, 2016, European urology.

Dashboard report on performance on select quality indicators to cancer care providers

Mats Lambe, Pär Stattin, David Robinson, 2016, Scandinavian journal of urology.

Suicide risk in men with prostate-specific antigen-detected early prostate cancer: a nationwide population-based cohort study from PCBaSe Sweden.

Mats Lambe, Pär Stattin, Hans Garmo, 2010, European urology.

Sequence variants at 22q13 are associated with prostate cancer risk.

Jin Woo Kim, Pär Stattin, Fredrik Wiklund, 2009, Cancer research.

Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study.

Pär Stattin, Ove Andrén, Jennifer R. Rider, 2013, European urology.

Comprehensive evaluation of genetic variation in the IGF1 gene and risk of prostate cancer

Pär Stattin, Mattias Johansson, Fredrik Wiklund, 2007, International journal of cancer.

Diabetes Mellitus and Prostate Cancer Risk; A Nationwide Case–Control Study within PCBaSe Sweden

Pär Stattin, Hans Garmo, Katja Fall, 2013, Cancer Epidemiology, Biomarkers & Prevention.